News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
71,008 Results
Type
Article (11737)
Company Profile (35)
Press Release (59232)
Multimedia
Podcasts (48)
Webinars (6)
Section
Business (16932)
Career Advice (1658)
Deals (2896)
Drug Delivery (58)
Drug Development (8554)
Employer Resources (112)
FDA (1905)
Job Trends (2203)
News (32143)
Policy (4691)
Tag
2027 Bio NC Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (684)
Accelerated approval (15)
Adcomms (14)
Allergies (42)
Alliances (4359)
ALS (36)
Alzheimer's disease (269)
Antibody-drug conjugate (ADC) (73)
Approvals (1818)
Artificial intelligence (158)
Autoimmune disease (37)
Automation (8)
Bankruptcy (48)
Best Places to Work (1615)
BIOSECURE Act (11)
Biosimilars (35)
Biotechnology (24)
Bladder cancer (21)
Brain cancer (14)
Breast cancer (76)
Cancer (716)
Cardiovascular disease (67)
Career advice (1381)
Career pathing (38)
CAR-T (54)
CDC (29)
Celiac Disease (1)
Cell therapy (183)
Cervical cancer (6)
Clinical research (6728)
Collaboration (276)
Company closure (4)
Compensation (69)
Complete response letters (25)
COVID-19 (786)
CRISPR (29)
C-suite (157)
Cystic fibrosis (16)
Data (882)
Decentralized trials (1)
Denatured (7)
Depression (47)
Dermatology (15)
Diabetes (114)
Diagnostics (713)
Digital health (8)
Diversity (5)
Diversity, equity & inclusion (29)
Drug discovery (73)
Drug pricing (97)
Drug shortages (13)
Duchenne muscular dystrophy (47)
Earnings (5145)
Editorial (65)
Employer branding (11)
Employer resources (103)
Events (8281)
Executive appointments (122)
FDA (2383)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (1)
Frontotemporal dementia (4)
Funding (281)
Gene editing (59)
Generative AI (20)
Gene therapy (186)
GLP-1 (300)
Government (1105)
Grass and pollen (2)
Guidances (41)
Healthcare (2641)
HIV (28)
Huntington's disease (16)
IgA nephropathy (7)
Immunology and inflammation (74)
Immuno-oncology (22)
Indications (19)
Infectious disease (849)
Inflammatory bowel disease (29)
Inflation Reduction Act (5)
Influenza (22)
Intellectual property (23)
Interviews (326)
IPO (1095)
IRA (26)
Job creations (572)
Job search strategy (1113)
JPM (41)
Kidney cancer (3)
Labor market (65)
Layoffs (173)
Leadership (38)
Legal (1648)
Liver cancer (14)
Longevity (7)
Lung cancer (88)
Lymphoma (48)
Machine learning (21)
Management (42)
Manufacturing (200)
MASH (20)
Medical device (1305)
Medtech (1313)
Mergers & acquisitions (1934)
Metabolic disorders (377)
mRNA (80)
Multiple sclerosis (13)
NASH (4)
Neurodegenerative disease (80)
Neuropsychiatric disorders (27)
Neuroscience (510)
NextGen: Class of 2026 (1251)
Non-profit (954)
Now hiring (15)
Obesity (226)
Opinion (253)
Ovarian cancer (17)
Pain (41)
Pancreatic cancer (38)
Parkinson's disease (44)
Partnered (17)
Patents (60)
Patient recruitment (69)
Peanut (6)
People (5619)
Pharmaceutical (5)
Pharmacy benefit managers (10)
Phase 1 (2230)
Phase 2 (2921)
Phase 3 (2414)
Pipeline (999)
Policy (188)
Postmarket research (251)
Preclinical (860)
Press Release (8)
Prostate cancer (33)
Psychedelics (26)
Radiopharmaceuticals (35)
Rare diseases (282)
Real estate (803)
Recruiting (49)
Regulatory (2917)
Reports (11)
Research institute (539)
Resumes & cover letters (289)
Rett syndrome (8)
RNA editing (6)
RSV (13)
Schizophrenia (24)
Series A (53)
Series B (30)
Service/supplier (1)
Sickle cell disease (26)
Special edition (12)
Spinal muscular atrophy (21)
Sponsored (19)
Startups (557)
Stomach cancer (5)
Supply chain (28)
Tariffs (48)
The Weekly (40)
Vaccines (323)
Venture capital (56)
Weight loss (195)
Women's health (32)
Worklife (19)
Date
Today (16)
Last 7 days (95)
Last 30 days (404)
Last 365 days (3700)
2026 (1471)
2025 (3700)
2024 (3722)
2023 (3862)
2022 (4866)
2021 (5707)
2020 (5675)
2019 (6141)
2018 (4815)
2017 (3585)
2016 (3793)
2015 (4185)
2014 (2788)
2013 (2154)
2012 (2397)
2011 (2456)
2010 (1672)
Location
Africa (325)
Alabama (7)
Alaska (1)
Arizona (17)
Arkansas (3)
Asia (3804)
Australia (900)
California (1475)
Canada (351)
China (125)
Colorado (52)
Connecticut (60)
Delaware (50)
Europe (9151)
Florida (167)
Georgia (29)
Idaho (5)
Illinois (108)
India (17)
Indiana (53)
Japan (54)
Kansas (24)
Kentucky (10)
Louisiana (9)
Maine (7)
Maryland (201)
Massachusetts (877)
Michigan (38)
Minnesota (46)
Mississippi (2)
Missouri (12)
Montana (5)
Nebraska (1)
Nevada (13)
New Hampshire (11)
New Jersey (307)
New Mexico (4)
New York (485)
North Carolina (114)
Northern California (636)
Ohio (41)
Oklahoma (5)
Oregon (5)
Pennsylvania (215)
Puerto Rico (1)
Rhode Island (6)
South America (345)
South Carolina (12)
Southern California (607)
Tennessee (19)
Texas (196)
United States (4671)
Utah (42)
Virginia (40)
Washington D.C. (19)
Washington State (73)
West Virginia (2)
Wisconsin (18)
71,008 Results for "just biotherapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
J&J’s Duato makes 358 times his median employee; Vertex CEO makes just 80 times
BioSpace
analyzed the pay ratio across 10 major pharmaceutical companies to determine which CEOs were paid the most relative to typical employees. J&J, Eli Lilly and Pfizer once again topped the list.
May 20, 2026
·
1 min read
·
Annalee Armstrong
FDA
Moderna’s Outright Flu Refusal Just the Latest Case of Crossed FDA Signals
The FDA’s refusal to review Moderna’s mRNA-based flu vaccine is part of a larger communications crisis unfolding at the agency over the past nine months that has also ensnarled Sarepta, Capricor, uniQure and many more.
February 13, 2026
·
6 min read
·
Heather McKenzie
Press Releases
Just - Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access
January 8, 2026
·
5 min read
Government
‘Just Agree to It:’ Pazdur Said He Was Told To Cosign FDA’s Reduced Trial Requirements
Richard Pazdur had spent 26 years at the FDA before stepping down last year due to disagreements with Commissioner Marty Makary about lowering the number of clinical trials required for a new drug application, Pazdur told the media.
February 16, 2026
·
2 min read
·
Tristan Manalac
Press Releases
FORE Biotherapeutics to Participate in Upcoming Investor Conferences - May 12, 2026
May 12, 2026
·
1 min read
Press Releases
Sernova Biotherapeutics Announces Closing of Recently Approved Financings
April 23, 2026
·
3 min read
Press Releases
Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform
April 30, 2026
·
6 min read
Press Releases
Calidi Biotherapeutics Confirms Featured Speaker Presentation Tomorrow at the ASGCT Conference in Boston
May 13, 2026
·
4 min read
Press Releases
Evotec Closes Sale of Just - Evotec Biologics’ Toulouse Site to Sandoz
December 8, 2025
·
5 min read
Press Releases
Atara Biotherapeutics Announces First Quarter 2026 Financial Results and Operational Progress
May 13, 2026
·
8 min read
1 of 7,101
Next
